TLR agonists as modulators of the innate immune response and their potential as agents against infectious disease
Loading...
Download
Associated Records
Authors
File Licence
Editors
Date
2014-01-01
Source Title
Frontiers in Immunology
Journal Title
Journal ISSN
Volume Title
Publisher
FRONTIERS MEDIA SA
Melbourne Authors
Affiliation
Microbiology and Immunology
Document Type
Journal Article
Subject Code
Citation
Mifsud, E. J., Tan, A. C. L. & Jackson, D. C. (2014). TLR agonists as modulators of the innate immune response and their potential as agents against infectious disease. Frontiers in Immunology, 5 (MAR), pp.1-10. https://doi.org/10.3389/fimmu.2014.00079.
Access Status
Open Access
Access URL
Open Access URL
Open Access at PMC
Linked Resource URL
NHMRC Grant Code
ARC Grant Code
Description
Abstract
Immunotherapies that can either activate or suppress innate immune responses are being investigated as treatments against infectious diseases and the pathology they can cause. The objective of these therapies is to elicit protective immune responses thereby limiting the harm inflicted by the pathogen. The Toll-like receptor (TLR) signaling pathway plays critical roles in numerous host immune defenses and has been identified as an immunotherapeutic target against the consequences of infectious challenge. This review focuses on some of the recent advances being made in the development of TLR-ligands as potential prophylactic and/or therapeutic agents.